$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2015-11-06 AccNo: 0001062822-15-000036 Size: 58 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接